Evaluation of metformin effect on progression of autosomal dominant polycystic kidney disease; a clinical trial
Phase 2
- Conditions
- Autosomal Dominant Polycystic Kidney Disease.Polycystic kidney, adult type
- Registration Number
- IRCT2012102111194N1
- Lead Sponsor
- Vice-chancellor for research,Tehran University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusion: Known case of Autosomal dominant polycystic kidney disease (by sonography); age between 18-60 years old; GFR>=60 cc/min.
Exclusion: history of diabetes mellitus; history of heart failure; history of liver failure
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Kidneys volume. Timepoint: 6 months. Method of measurement: Magnetic Resonance Imaging.
- Secondary Outcome Measures
Name Time Method